Has Pemetrexed revived the Doctrine of Equivalence?

By Widera P.


This article focuses on the development of claim construction and the Doctrine of Equivalence in Germany and the UK before and after the Pemetrexed-decisions in Actavis v. Eli Lilly by the respective Supreme Courts. While especially the UK decision came as a huge surprise, positive aspects can be derived from …read more

Source:: Journal of Intellectual Property Law & Practice